Skip to main content

Table 1 HPV prevalence and genotype distribution in relation to cervical cytology status

From: HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia

 

All cases (N = 233)

Normal cytology (N = 141)

Abnormal cytology (N = 92)

TOTAL (n = 92)

LSIL (n = 6)

HSIL (n = 63)

ICC (n = 23)

Any HPV

161 (69.1)

69 (48.9)

92 (100)

6 (100)

63 (100)

23 (100)

LR-HPV

24 (15.2)

17 (25.8)

7 (7.6)

1 (16.7)

3 (4.8)

3 (13)

Multiple HPV

3 (1.86)

1 (1.5)

2 (2.2)

 

2 (3.2)

 

Untypable

3 (1.9)

3 (4.4)

    

HR-HPV

134 (83.2)

49 (71.0)

85 (92.4)

5 (83.3)

65 (95.2)

20 (87.0)

 HPV-16

71 (44.1)

14 (20.3)

57 (62.0)

4 (66.7)

40 (63.5)

13 (56.5)

 HPV-18

5 (3.1)

3 (4.4)

2 (2.2)

 

2 (3.2)

 

 HPV-31

7 (4.4)

3 (4.4)

4 (4.4)

 

4 (6.4)

 

 HPV-35

10 (6.2)

6 (8.7)

4 (4.4)

 

3 (4.8)

1 (4.4)

 HPV-39

3 (1.9)

3 (4.4)

    

 HPV-45

10 (6.2)

2 (2.9)

8 (8.7)

1 (16.7)

4 (6.4)

3 (13.0)

 HPV-52

2 (1.2)

 

2 (2.2)

  

2 (8.7)

 HPV-56

6 (3.7)

4 (5.8)

2 (2.2)

 

1 (1.6)

1 (4.4)

 HPV-58

4 (2.5)

4 (5.8)

    

 HPV-59

5 (3.1)

1 (1.5)

4 (4.4)

 

4 (6.4)

 

 HPV-68

1 (0.6)

1 (1.5)

    

pHR-HPV

 HPV-53

2 (1.2)

2 (2.9)

    

 HPV-66

1 (0.6)

1 (1.5)

    

 HPV-70

4 (2.5)

3 (4.4)

1 (1.1)

 

1 (1.6)

 

 HPV-73

3 (1.9)

2 (2.9)

1 (1.1)

 

1 (1.6)

 
  1. LR low-risk, HR high-risk, pHR probable-HR, LSIL low-grade squamous intraepithelial lesion, HSIL high-grade squamous intraepithelial lesion, ICC invasive cervical carcinoma